Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 2
1971 1
1975 1
1976 3
1977 1
1978 2
1979 1
1980 1
1981 2
1982 1
1983 3
1984 2
1985 3
1986 3
1987 4
1988 2
1989 1
1990 4
1991 1
1992 4
1993 2
1994 4
1995 1
1996 2
1997 4
1998 6
1999 3
2000 5
2001 5
2002 2
2003 5
2004 6
2005 5
2006 4
2007 8
2008 9
2009 9
2010 10
2011 13
2012 19
2013 13
2014 12
2015 7
2016 1
2017 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).
Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, Zackheim H, Duvic M, Estrach T, Lamberg S, Wood G, Dummer R, Ranki A, Burg G, Heald P, Pittelkow M, Bernengo MG, Sterry W, Laroche L, Trautinger F, Whittaker S; ISCL/EORTC. Olsen E, et al. Among authors: bernengo mg. Blood. 2007 Sep 15;110(6):1713-22. doi: 10.1182/blood-2007-03-055749. Epub 2007 May 31. Blood. 2007. PMID: 17540844 Free article. Review.
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.
Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, Wood GS, Willemze R, Demierre MF, Pimpinelli N, Bernengo MG, Ortiz-Romero PL, Bagot M, Estrach T, Guitart J, Knobler R, Sanches JA, Iwatsuki K, Sugaya M, Dummer R, Pittelkow M, Hoppe R, Parker S, Geskin L, Pinter-Brown L, Girardi M, Burg G, Ranki A, Vermeer M, Horwitz S, Heald P, Rosen S, Cerroni L, Dreno B, Vonderheid EC; International Society for Cutaneous Lymphomas; United States Cutaneous Lymphoma Consortium; Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. Olsen EA, et al. Among authors: bernengo mg. J Clin Oncol. 2011 Jun 20;29(18):2598-607. doi: 10.1200/JCO.2010.32.0630. Epub 2011 May 16. J Clin Oncol. 2011. PMID: 21576639 Free PMC article.
The Sézary syndrome: hematologic criteria.
Vonderheid EC, Bernengo MG. Vonderheid EC, et al. Among authors: bernengo mg. Hematol Oncol Clin North Am. 2003 Dec;17(6):1367-89, viii. doi: 10.1016/s0889-8588(03)00120-5. Hematol Oncol Clin North Am. 2003. PMID: 14710890 Review.
Mycosis fungoides: disease evolution of the "lion queen" revisited.
Quaglino P, Pimpinelli N, Berti E, Calzavara-Pinton P, Lombardo GA, Rupoli S, Alaibac M, Arcaini L, Bagnato S, Baldo A, Bottoni U, Carbone A, Cestari R Clerico R, De Renzo A, Fava P, Fierro MT, Filotico R, Fimiani M, Frontani M Girgenti V, Goteri G, Leali C, Mamusa AM, Mariotti G, Mastrandrea V, Pellegrini C, Pennese E, Pileri A, Savoia P, Stelitano C, Titli S, Virgili A, Zichichi L, Zinzani PL, Bernengo MG. Quaglino P, et al. Among authors: bernengo mg. G Ital Dermatol Venereol. 2012 Dec;147(6):523-31. G Ital Dermatol Venereol. 2012. PMID: 23149698 Review.
Multiple primary melanomas: analysis of 49 cases.
Savoia P, Quaglino P, Verrone A, Bernengo MG. Savoia P, et al. Among authors: bernengo mg. Melanoma Res. 1998 Aug;8(4):361-6. doi: 10.1097/00008390-199808000-00010. Melanoma Res. 1998. PMID: 9764812 Review.
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
Ascierto PA, Simeone E, Sileni VC, Pigozzo J, Maio M, Altomonte M, Del Vecchio M, Di Guardo L, Marchetti P, Ridolfi R, Cognetti F, Testori A, Bernengo MG, Guida M, Marconcini R, Mandalà M, Cimminiello C, Rinaldi G, Aglietta M, Queirolo P. Ascierto PA, et al. Among authors: bernengo mg. J Transl Med. 2014 May 7;12:116. doi: 10.1186/1479-5876-12-116. J Transl Med. 2014. PMID: 24885479 Free PMC article.
Atopic dermatitis in a phenylketonuric untreated patient.
Fava P, Fierro MT, Brizio M, Marra E, Spada M, Bernengo MG. Fava P, et al. Among authors: bernengo mg. Int J Dermatol. 2015;54(5):568-70. doi: 10.1111/ijd.12043. Epub 2013 Jun 20. Int J Dermatol. 2015. PMID: 23786551 Free article. No abstract available.
179 results